Amgen Inc. Goodwill, Other Changes (Deprecated 2016-01-31)
Amgen Inc. (AMGN) reported Goodwill, Other Changes (Deprecated 2016-01-31) of $66.00 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-02-19.
Discontinued › Notes › Intangible Assets
us-gaap:GoodwillOtherChanges · last filed 2015-02-19
- Amgen Inc. goodwill, other changes (deprecated 2016-01-31) for the quarter ending 2012-03-31 was $3.00M.
- Amgen Inc. goodwill, other changes (deprecated 2016-01-31) for the quarter ending 2011-12-31 was -$2.00M.
- Amgen Inc. goodwill, other changes (deprecated 2016-01-31) for the quarter ending 2011-09-30 was -$17.00M.
- Amgen Inc. goodwill, other changes (deprecated 2016-01-31) for fiscal 2014 was $66.00M, a 27.47% decline from fiscal 2013.
- Amgen Inc. goodwill, other changes (deprecated 2016-01-31) for fiscal 2013 was $91.00M, a 468.75% increase from fiscal 2012.
- Amgen Inc. goodwill, other changes (deprecated 2016-01-31) for fiscal 2012 was $16.00M.
- Amgen Inc. goodwill, other changes (deprecated 2016-01-31) for fiscal 2011 was -$19.00M.
| Period end | Goodwill, Other Changes (Deprecated 2016-01-31) 3 month | Goodwill, Other Changes (Deprecated 2016-01-31) 6 month | Goodwill, Other Changes (Deprecated 2016-01-31) 9 month | Goodwill, Other Changes (Deprecated 2016-01-31) 12 month | Goodwill, Other Changes (Deprecated 2016-01-31) 12 month as first filed |
|---|---|---|---|---|---|
| 2014-12-31 | $66.00M 10-K · filed 2015-02-19 | ||||
| 2013-12-31 | $91.00M 10-K · filed 2015-02-19 | $220.00M 10-K · filed 2014-02-24 | |||
| 2012-12-31 | $16.00M 10-K · filed 2014-02-24 | ||||
| 2012-03-31 | $3.00M 10-Q · filed 2012-05-08 | $1.00M derived: sum of 2 quarters · filed 2012-05-08 | -$16.00M derived: sum of 3 quarters · filed 2012-05-08 | ||
| 2011-12-31 | -$2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | -$19.00M derived: sum of 2 quarters · filed 2012-02-29 | -$19.00M 10-K · filed 2012-02-29 | ||
| 2011-09-30 | -$17.00M 10-Q · filed 2011-11-04 | -$17.00M 10-Q · filed 2011-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | United States | $185.522B | -48.37 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |